Target price | $27.79 |
Course | $8.05 |
Price potential |
245.18%
register free of charge
|
Number of estimates | 4 |
4 Analysts have issued a price target Pharming Group N.V. - ADR 2025 .
The average Pharming Group N.V. - ADR target price is $27.79.
This is
245.18%
register free of charge
$40.00
396.89%
register free of charge
$16.26
102.01%
register free of charge
|
|
A rating was issued by 5 analysts: 5 Analysts recommend Pharming Group N.V. - ADR to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst estimates: Analysts believe that the Pharming Group N.V. - ADR share has an average upside potential 2025 of
245.18%
register free of charge
|
Dec '23 |
2024 Forecast |
|
---|---|---|
Turnover Million $ | 245.70 | 287.61 |
19.43% | 17.06% | |
EBITDA margin | -4.49% | 2.61% |
173.42% | 158.09% | |
Net margin | -4.37% | 2.33% |
163.80% | 153.32% |
3 Analysts have issued a sales forecast Pharming Group N.V. - ADR 2024 . The average Pharming Group N.V. - ADR sales estimate is
This results in the following potential growth figures:
2 Analysts have issued an Pharming Group N.V. - ADR EBITDA forecast 2024. The average Pharming Group N.V. - ADR EBITDA estimate is
This results in the following potential growth figures and future EBITDA margins:
Dec '23 |
2024 Forecast |
|
---|---|---|
Earnings per share $ | -0.16 | 0.10 |
176.19% | 162.50% | |
P/E ratio | 80.50 | |
EV/Sales | 1.76 |
Based on analysts' sales estimates for 2024, the Pharming Group N.V. - ADR share is valued at an <a href=/blog/ev-sales-einfach-erklaert>EV/Sales of
This results in the following potential growth figures and future valuations:
Pharming Group N.V. - ADR...
StocksGuide is the tool for easily finding, analyzing and monitoring shares. Learn from successful investors and make well-founded investment decisions. We make you a self-determined investor.